- Home
- WFRD vs ASND Comparison
WFRD vs ASND Comparison
Compare WFRD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WFRD | ASND |
|---|---|---|
| Founded | 1941 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 12.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | WFRD | ASND |
|---|---|---|
| Price | $86.47 | $212.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 15 |
| Target Price | $93.22 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 1.0M | 700.6K |
| Earning Date | 02-03-2026 | 02-11-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.52 | N/A |
| Revenue | ★ $4,970,000,000.00 | $758,592,045.00 |
| Revenue This Year | N/A | $98.90 |
| Revenue Next Year | N/A | $83.74 |
| P/E Ratio | $16.19 | ★ N/A |
| Revenue Growth | N/A | ★ 97.46 |
| 52 Week Low | $36.74 | $118.03 |
| 52 Week High | $91.23 | $229.94 |
Technical Indicators
Market Signals| Indicator | WFRD | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 65.12 | 53.38 |
| Support Level | $77.63 | $204.50 |
| Resistance Level | $91.23 | $215.98 |
| Average True Range (ATR) | 2.26 | 7.45 |
| MACD | 0.79 | 0.25 |
| Stochastic Oscillator | 70.01 | 67.58 |
Price Performance
Historical ComparisonAbout WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.